BIOMAT Database Logo BIOMAT Database Logo

Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV. 2023

Camilla Muccini, and Laura Galli, and Michela Sampaolo, and Nicola Gianotti, and Antonella Castagna, and Diana Canetti
Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019427 HIV Integrase Enzyme of the HUMAN IMMUNODEFICIENCY VIRUS that is required to integrate viral DNA into cellular DNA in the nucleus of a host cell. HIV integrase is a DNA nucleotidyltransferase encoded by the pol gene. HIV Integration Protein,p31 Integrase Protein, HIV,p31 Integrase Protein, Human Immunodeficiency Virus,p31 pol Gene Product, HIV,p31 pol Gene Product, Human Immunodeficiency Virus,Integrase, HIV,Integration Protein, HIV
D019428 HIV Integrase Inhibitors Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA. Integrase Inhibitors, HIV,Inhibitors, HIV Integrase
D024882 Drug Resistance, Viral The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation. Antiviral Drug Resistance,Antiviral Drug Resistances,Drug Resistances, Viral

Related Publications

Camilla Muccini, and Laura Galli, and Michela Sampaolo, and Nicola Gianotti, and Antonella Castagna, and Diana Canetti
Integrase Inhibitor-Based Antiretroviral Therapy Among Women Living with HIV: Data from the OPERA Cohort.
January 2019, Current HIV research,
Camilla Muccini, and Laura Galli, and Michela Sampaolo, and Nicola Gianotti, and Antonella Castagna, and Diana Canetti
Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Therapy-Naive and Treatment-Experienced HIV Patients in South Korea.
February 2019, AIDS research and human retroviruses,
Camilla Muccini, and Laura Galli, and Michela Sampaolo, and Nicola Gianotti, and Antonella Castagna, and Diana Canetti
Similar plasma lipidomic profile in people living with HIV treated with a darunavir-based or an integrase inhibitor-based antiretroviral therapy.
November 2019, Scientific reports,
Camilla Muccini, and Laura Galli, and Michela Sampaolo, and Nicola Gianotti, and Antonella Castagna, and Diana Canetti
Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
January 2021, The Journal of antimicrobial chemotherapy,
Camilla Muccini, and Laura Galli, and Michela Sampaolo, and Nicola Gianotti, and Antonella Castagna, and Diana Canetti
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.
February 2005, The Journal of infectious diseases,
Camilla Muccini, and Laura Galli, and Michela Sampaolo, and Nicola Gianotti, and Antonella Castagna, and Diana Canetti
Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapy.
September 2022, AIDS (London, England),
Camilla Muccini, and Laura Galli, and Michela Sampaolo, and Nicola Gianotti, and Antonella Castagna, and Diana Canetti
Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda.
June 2021, AIDS (London, England),
Camilla Muccini, and Laura Galli, and Michela Sampaolo, and Nicola Gianotti, and Antonella Castagna, and Diana Canetti
Response to Therapy in Antiretroviral Therapy-Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor-Associated Transmitted Drug Resistance.
June 2016, Journal of acquired immune deficiency syndromes (1999),
Camilla Muccini, and Laura Galli, and Michela Sampaolo, and Nicola Gianotti, and Antonella Castagna, and Diana Canetti
Glycemic Control in Patients Living With HIV Initiated on Integrase Inhibitor-Based Three-Drug Antiretroviral Therapy.
April 2024, The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians,
Camilla Muccini, and Laura Galli, and Michela Sampaolo, and Nicola Gianotti, and Antonella Castagna, and Diana Canetti
Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy.
August 2010, Journal of acquired immune deficiency syndromes (1999),
Copied contents to your clipboard!